Welcome to the BioPharmaceutical Emerging Best Practices Association (BEBPA) , a non-profit organization managed by and for the benefit of the biopharmaceutical scientific community.  BEBPA provides an international forum for the presentation and discussion of scientific issues and problems encountered in the biopharmaceutical community.  The aim of this open discussion is to promote development of innovative approaches and solutions thus facilitating safer and faster biopharmaceutical product development.

One of BEBPA’s aims is to foster publication of white papers clarifying problems faced by biopharmaceutical community – companies, regulators, clinicians – during product development and identifying emerging issues which could benefit from early discussion.  Smaller conferences will then be held on these topics and a non-consensus white paper will be published delineating various approaches to solving these problems.  The papers are not intended to be guidance documents, but rather will strive to present the scientific community with a variety of approaches to potentially solve a common problem.  Since the papers are not consensus documents, nor prescribe a preferred approach, publication will occur rapidly and thus be part of the scientific discussion.  Additionally it is hoped that the  publication of potential problem-solving approaches the biopharmaceutical scientific community will accelerate the rate at which a future consensus best practice can be established.